BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 17729164)

  • 1. Effect of Boron Neutron Capture Therapy (BNCT) on normal liver regeneration: towards a novel therapy for liver metastases.
    Cardoso JE; Trivillin VA; Heber EM; Nigg DW; Calzetta O; Blaumann H; Longhino J; Itoiz ME; Bumaschny E; Pozzi E; Schwint AE
    Int J Radiat Biol; 2007 Oct; 83(10):699-706. PubMed ID: 17729164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model.
    Aromando RF; Heber EM; Trivillin VA; Nigg DW; Schwint AE; Itoiz ME
    J Oral Pathol Med; 2009 May; 38(5):448-54. PubMed ID: 19141057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT.
    Monti Hughes A; Heber EM; Pozzi E; Nigg DW; Calzetta O; Blaumann H; Longhino J; Nievas SI; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S313-7. PubMed ID: 19376711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model.
    Kamida A; Obayashi S; Kato I; Ono K; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Int J Radiat Biol; 2006 Jan; 82(1):21-9. PubMed ID: 16546900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiobiology of BNCT mediated by GB-10 and GB-10+BPA in experimental oral cancer.
    Trivillin VA; Heber EM; Itoiz ME; Nigg D; Calzetta O; Blaumann H; Longhino J; Schwint AE
    Appl Radiat Isot; 2004 Nov; 61(5):939-45. PubMed ID: 15308172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology.
    Trivillin VA; Heber EM; Nigg DW; Itoiz ME; Calzetta O; Blaumann H; Longhino J; Schwint AE
    Radiat Res; 2006 Aug; 166(2):387-96. PubMed ID: 16881740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect of boron neutron capture therapy (BNCT) on field cancerized tissue: inhibition of DNA synthesis and lag in the development of second primary tumors in precancerous tissue around treated tumors in DMBA-induced carcinogenesis in the hamster cheek pouch oral cancer model.
    Heber EM; Aromando RF; Trivillin VA; Itoiz ME; Nigg DW; Kreimann EL; Schwint AE
    Arch Oral Biol; 2007 Mar; 52(3):273-9. PubMed ID: 17137553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
    Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine.
    Kreimann EL; Itoiz ME; Dagrosa A; Garavaglia R; Farías S; Batistoni D; Schwint AE
    Cancer Res; 2001 Dec; 61(24):8775-81. PubMed ID: 11751398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homogeneous boron targeting of heterogeneous tumors for boron neutron capture therapy (BNCT): chemical analyses in the hamster cheek pouch oral cancer model.
    Heber EM; Trivillin VA; Nigg DW; Itoiz ME; Gonzalez BN; Rebagliati RJ; Batistoni D; Kreimann EL; Schwint AE
    Arch Oral Biol; 2006 Oct; 51(10):922-9. PubMed ID: 16696934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution of GB-10 (Na(2)(10)B10H10 compound for boron neutron capture therapy (BNCT) in an experimental model of oral cancer in the hamster cheek pouch.
    Heber E; Trivillin VA; Nigg D; Kreimann EL; Itoiz ME; Rebagliati RJ; Batistoni D; Schwint AE
    Arch Oral Biol; 2004 Apr; 49(4):313-24. PubMed ID: 15003550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma.
    Morris GM; Micca PL; Coderre JA
    Appl Radiat Isot; 2004 Nov; 61(5):917-21. PubMed ID: 15308168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
    Ferrari C; Zonta C; Cansolino L; Clerici AM; Gaspari A; Altieri S; Bortolussi S; Stella S; Bruschi P; Dionigi P; Zonta A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
    Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
    Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Sequential" boron neutron capture therapy (BNCT): a novel approach to BNCT for the treatment of oral cancer in the hamster cheek pouch model.
    Molinari AJ; Pozzi EC; Monti Hughes A; Heber EM; Garabalino MA; Thorp SI; Miller M; Itoiz ME; Aromando RF; Nigg DW; Quintana J; Santa Cruz GA; Trivillin VA; Schwint AE
    Radiat Res; 2011 Apr; 175(4):463-72. PubMed ID: 21294607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
    Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
    Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution of the boron carriers boronophenylalanine (BPA) and/or decahydrodecaborate (GB-10) for Boron Neutron Capture Therapy (BNCT) in an experimental model of lung metastases.
    Trivillin VA; Garabalino MA; Colombo LL; González SJ; Farías RO; Monti Hughes A; Pozzi EC; Bortolussi S; Altieri S; Itoiz ME; Aromando RF; Nigg DW; Schwint AE
    Appl Radiat Isot; 2014 Jun; 88():94-8. PubMed ID: 24360862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
    Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
    Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.